Ignite Creation Date:
2024-05-06 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 12:01 PM
Study NCT ID:
NCT02754011
Status:
COMPLETED
Last Update Posted:
2023-12-07
First Post:
2016-02-19
Brief Title:
Phase I Evaluating the Combination of RibociclibCapecitabine in Locally AdvancedMetastatic Breast Cancer HER2 Negative
Sponsor:
UNICANCER
Organization:
UNICANCER
Organization Data
Organization:
UNICANCER
Class:
OTHER
Study ID:
UC-01011504
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
UNICANCER
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Novartis | INDUSTRY |